Role of contrast-enhanced ultrasound in follow-up assessment after ablation for hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 19, Issue 6, 2013, Pages 855-865

  Zheng, Shu Guang ^a,b   Xu, Hui Xiong ^a,b   Lu, Ming De ^a   Xie, Xiao Yan ^a   Xu, Zuo Feng ^a   Liu, Guang Jian ^a   Liu, Lin Na ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b TENTH PEOPLE S HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

Contrast enhanced ultrasound; Contrastenhanced computed tomography; Hepatocellular carcinoma; Microwave ablation; Radiofrequency ablation

Indexed keywords

IOPROMIDE; SONOVUE;

ABLATION THERAPY; ADULT; AGED; ARTICLE; CANCER RECURRENCE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROWAVE THERAPY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; TUMOR GROWTH;

EID: 84873701957     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i6.855     Document Type: Article

References (36)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. [PMID: 15761078 DOI: 10.3322/caac.20107]
2. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022. [PMID: 21374666 DOI: 10.1002/hep.24199]
3. Kim SK, Lim HK, Kim YH, Lee WJ, Lee SJ, Kim SH, Lim JH, Kim SA. Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings. Radio-graphics 2003; 23: 107-121. [PMID: 12533646 DOI: 10.1148/ rg.231025055]
4. Xu HX, Wang Y, Lu MD, Liu LN. Percutaneous ultrasound-guided thermal ablation for intrahepatic cholangiocarcinoma. Br J Radiol 2012; 85: 1078-1084. [PMID: 22374282 DOI: 10.1259/bjr/24563774]
5. Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 2008; 48 (Suppl 1): S20-S37. [PMID: 18304676 DOI: 10.1016/j.jhep.2008.01.022]
6. Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, Rossi S. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology 2008; 47: 82-89. [PMID: 18008357 DOI: 10.1002/hep.21933]
7. Tiong L, Maddern GJ. Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2011; 98: 1210-1224. [PMID: 21766289 DOI: 10.1002/bjs.7669]
8. Salvaggio G, Campisi A, Lo Greco V, Cannella I, Meloni MF, Caruso G. Evaluation of posttreatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT. Abdom Imaging 2010; 35: 447-453. [PMID: 19562414 DOI: 10.1007/s00261-009-9551-6]
9. Solbiati L, Ierace T, Tonolini M, Cova L. Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol 2004; 51 Suppl: S19-S23. [PMID: 15311434]
10. Sparchez Z, Radu P, Anton O, Socaciu M, Badea R. Contrast enhanced ultrasound in assessing therapeutic response in ablative treatments of hepatocellular carcinoma. J Gastrointestin Liver Dis 2009; 18: 243-248. [PMID: 19565061]
11. Lu MD, Yu XL, Li AH, Jiang TA, Chen MH, Zhao BZ, Zhou XD, Wang JR. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China. Ultrasound Med Biol 2007; 33: 1736-1749. [PMID: 17629608 DOI: 10.1016/ j.ultrasmedbio.2007.05.004]
12. Ricci P, Cantisani V, Drudi F, Pagliara E, Bezzi M, Meloni F, Calliada F, Erturk SM, D'Andrea V, D'Ambrosio U, Passariello R. Is contrast-enhanced US alternative to spiral CT in the assessment of treatment outcome of radiofrequency ablation in hepatocellular carcinoma? Ultraschall Med 2009; 30: 252-258. [PMID: 19280552 DOI: 10.1055/s-2008-1027727]
13. Vilana R, Bianchi L, Varela M, Nicolau C, Sánchez M, Ayuso C, García M, Sala M, Llovet JM, Bruix J, Bru C. Is micro-bubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? Eur Radiol 2006; 16: 2454-2462. [PMID: 16710666 DOI: 10.1007/s00330-006-0264-8]
14. Xu HX, Lu MD, Liu LN, Zhang YF, Guo LH, Xu JM, Liu C. Discrimination between neoplastic and non-neoplastic lesions in cirrhotic liver using contrast-enhanced ultrasound. Br J Radiol 2012; 85: 1376-1384. [PMID: 22553290 DOI: 10.1259/bjr/19932596]
15. Claudon M, Cosgrove D, Albrecht T, Bolondi L, Bosio M, Calliada F, Correas JM, Darge K, Dietrich C, D'Onofrio M, Evans DH, Filice C, Greiner L, Jäger K, Jong Nd, Leen E, Lencioni R, Lindsell D, Martegani A, Meairs S, Nolsøe C, Piscaglia F, Ricci P, Seidel G, Skjoldbye B, Solbiati L, Thorelius L, Tranquart F, Weskott HP, Whittingham T. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - Update 2008. Ultraschall Med 2008; 29: 28-44 [PMID: 18270887 DOI: 10.1055/s-2007-963785]
16. Xu HX, Chen LD, Xie XY, Xie XH, Xu ZF, Liu GJ, Lin MX, Wang Z, Lu MD. Enhancement pattern of hilar cholangio-carcinoma: contrast-enhanced ultrasound versus contrast-enhanced computed tomography. Eur J Radiol 2010; 75: 197-202. [PMID: 19464836 DOI: 10.1016/j.ejrad.2009.04.060]
17. Xu HX, Xie XY, Lu MD, Liu GJ, Xu ZF, Zheng YL, Liang JY, Chen LD. Contrast-enhanced sonography in the diagnosis of small hepatocellular carcinoma < or = 2 cm. J Clin Ultrasound 2008; 36: 257-266. [PMID: 18088056 DOI: 10.1002/ jcu.20433]
18. Liu GJ, Xu HX, Lu MD, Xie XY, Xu ZF, Zheng YL, Liang JY. Correlation between enhancement pattern of hepatocellular carcinoma on real-time contrast-enhanced ultrasound and tumour cellular differentiation on histopathology. Br J Radiol 2007; 80: 321-330. [PMID: 17005515 DOI: 10.1259/ bjr/54805002]
19. Liu GJ, Xu HX, Lu MD, Xie XY, Xu ZF, Zheng YL, Liang JY. Enhancement pattern of hepatocellular carcinoma: comparison of real-time contrast-enhanced ultrasound and contrast-enhanced computed tomography. Clin Imaging 2006; 30: 315-321. [PMID: 16919551 DOI: 10.1016/j.clinimag.2006.03.031]
20. Kim CK, Choi D, Lim HK, Kim SH, Lee WJ, Kim MJ, Lee JY, Jeon YH, Lee J, Lee SJ, Lim JH. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol 2005; 56: 66-73. [PMID: 15913940 DOI: 10.1016/j.ejrad.2005.03.023]
21. Xu HX, Lu MD. Comparison between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas - A reply. Clin Radiol 2006; 61: 801-802 [DOI: 10.1016/j.crad.2006.05.005]
22. Lu MD, Yin XY, Xie XY, Xu HX, Xu ZF, Liu GJ, Kuang M, Zheng YL. Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy. Br J Surg 2005; 92: 1393-1398. [PMID: 16044409 DOI: 10.1002/bjs.5102]
23. Wong SN, Lin CJ, Lin CC, Chen WT, Cua IH, Lin SM. Combined percutaneous radiofrequency ablation and ethanol injection for hepatocellular carcinoma in high-risk locations. AJR Am J Roentgenol 2008; 190: W187-W195. [PMID: 18287411 DOI: 10.2214/AJR.07.2537]
24. Luo BM, Wen YL, Yang HY, Zhi H, Xiao XY, Ou B, Pan JS, Ma JH. Percutaneous ethanol injection, radiofrequency and their combination in treatment of hepatocellular carcinoma. World J Gastroenterol 2005; 11: 6277-6280. [PMID: 16419155]
25. Mahnken AH, Bruners P, Günther RW. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation. Dig Dis 2009; 27: 148-156. [PMID: 19546553 DOI: 10.1159/000218347]
26. Kuang M, Lu MD, Xie XY, Xu HX, Mo LQ, Liu GJ, Xu ZF, Zheng YL, Liang JY. Liver cancer: increased microwave delivery to ablation zone with cooled-shaft antenna--experimental and clinical studies. Radiology 2007; 242: 914-924. [PMID: 17229876 DOI: 10.1148/radiol.2423052028]
27. Kuang M, Lu MD, Xie XY, Xu HX, Xu ZF, Liu GJ, Yin XY, Huang JF, Lencioni R. Ethanol ablation of hepatocellular carcinoma Up to 5.0 cm by using a multipronged injection needle with high-dose strategy. Radiology 2009; 253: 552-561. [PMID: 19709992 DOI: 10.1148/radiol.2532082021]
28. Bartolotta TV, Taibbi A, Midiri M, De Maria M. Hepatocellular cancer response to radiofrequency tumor ablation: contrast-enhanced ultrasound. Abdom Imaging 2008; 33: 501-511. [PMID: 17786507 DOI: 10.1007/s00261-007-9294-1]
29. Jang HJ, Yu H, Kim TK. Contrast-enhanced ultrasound in the detection and characterization of liver tumors. Cancer Imaging 2009; 9: 96-103. [PMID: 19933022 DOI: 10.1102/1470-7330.2009.0015]
30. Hoeffel C, Job L, Ladam-Marcus V, Vitry F, Cadiot G, Marcus C. Detection of hepatic metastases from carcinoid tumor: prospective evaluation of contrast-enhanced ultrasonography. Dig Dis Sci 2009; 54: 2040-2046. [PMID: 19034651 DOI: 10.1007/s10620-008-0570-x]
31. Larsen LP, Rosenkilde M, Christensen H, Bang N, Bolvig L, Christiansen T, Laurberg S. Can contrast-enhanced ultrasonography replace multidetector-computed tomography in the detection of liver metastases from colorectal cancer? Eur J Radiol 2009; 69: 308-313. [PMID: 18068925 DOI: 10.1016/ j.ejrad.2007.10.023]
32. Correas JM, Low G, Needleman L, Robbin ML, Cosgrove D, Sidhu PS, Harvey CJ, Albrecht T, Jakobsen JA, Brabrand K, Jenett M, Bates J, Claudon M, Leen E. Contrast enhanced ultrasound in the detection of liver metastases: a prospective multi-centre dose testing study using a perfluorobutane microbubble contrast agent (NC100100). Eur Radiol 2011; 21: 1739-1746. [PMID: 21479856 DOI: 10.1007/s00330-011-2114-6]
33. Nicolau C, Catalá V, Vilana R, Gilabert R, Bianchi L, Solé M, Pagés M, Brú C. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 2004; 14: 1092-1099. [PMID: 15007620 DOI: 10.1007/ s00330-004-2298-0]
34. Pompili M, Riccardi L, Covino M, Barbaro B, Di Stasi C, Orefice R, Gasbarrini G, Rapaccini GL. Contrast-enhanced gray-scale harmonic ultrasound in the efficacy assessment of ablation treatments for hepatocellular carcinoma. Liver Int 2005; 25: 954-961. [PMID: 16162152 DOI: 10.1111/ j.1478-3231.2005.01135.x]
35. Lencioni R, Piscaglia F, Bolondi L. Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. J Hepatol 2008; 48: 848-857. [PMID: 18328590 DOI: 10.1016/ j.jhep.2008.02.005]
36. Bolondi L, Gaiani S, Celli N, Golfieri R, Grigioni WF, Leoni S, Venturi AM, Piscaglia F. Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 2005; 42: 27-34. [PMID: 15954118 DOI: 10.1002/hep.20728]